Impact of preinterventional tricuspid regurgitation on outcome of MitraClip therapy in patients with severely reduced ejection fraction
AimTo evaluate the impact of preinterventional moderate-to-severe functional tricuspid regurgitation (FTR) on early outcome after percutaneous edge-to-edge mitral valve repair (pMVR) with MitraClip procedures for functional mitral regurgitation (FMR) in patients with heart failure with reduced eject...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2020-06-01
|
Series: | Open Heart |
Online Access: | https://openheart.bmj.com/content/7/1/e001203.full |
_version_ | 1818435627922751488 |
---|---|
author | Takayuki Gyoten Daniel Messroghli Soeren Schenk Kristin Rochor Oliver Grimmig Soeren Just Dirk Fritzsche |
author_facet | Takayuki Gyoten Daniel Messroghli Soeren Schenk Kristin Rochor Oliver Grimmig Soeren Just Dirk Fritzsche |
author_sort | Takayuki Gyoten |
collection | DOAJ |
description | AimTo evaluate the impact of preinterventional moderate-to-severe functional tricuspid regurgitation (FTR) on early outcome after percutaneous edge-to-edge mitral valve repair (pMVR) with MitraClip procedures for functional mitral regurgitation (FMR) in patients with heart failure with reduced ejection fraction (HFrEF).Methods and resultsFrom January 2013 to December 2017, 80 patients with HFrEF (ejection fraction 22%±5.3%) and FMR (grade 3.0±0.36) underwent successful pMVR. The 3-year actuarial survival was 58%. However, 73% (n=22) of non-survivors died of cardiac failure within 1 year. Patients were categorised into none-to-mild (n=36) and moderate-to-severe (n=44) postinterventional FTR groups according to pre-MitraClip tricuspid regurgitation grade. Cox regression analysis on 1-year survival demonstrated an impact of FTR severity (HR=1.8, 95% CI 1.01% to 3.09%, p=0.047), preoperative New York Heart Association class (HR=2.8, 95% CI 1.2% to 6.5%, p=0.015) and peripheral artery disease (HR=5.4, 95% CI 1.6 to 18, p=0.0054). Kaplan-Meier analysis showed that 1-year cardiac death was higher in the moderate-to-severe FTR group (p=0.048). In our study, 77% of pre-MitraClip moderate-to-severe FTR cannot be significantly reduced. Post-MitraClip moderate-to-severe FTR grade was related to lower survival (p<0.001).ConclusionIn patients with HFrEF treated with MitraClip for FMR, moderate-to-severe FTR was an independent predictor of cardiac death within 1 year. To improve survival, additional therapy to residual FTR should be considered in early phase after MitraClip therapy. |
first_indexed | 2024-12-14T16:55:54Z |
format | Article |
id | doaj.art-58a55fdd72734c2d840770703af1cc59 |
institution | Directory Open Access Journal |
issn | 2053-3624 |
language | English |
last_indexed | 2024-12-14T16:55:54Z |
publishDate | 2020-06-01 |
publisher | BMJ Publishing Group |
record_format | Article |
series | Open Heart |
spelling | doaj.art-58a55fdd72734c2d840770703af1cc592022-12-21T22:53:58ZengBMJ Publishing GroupOpen Heart2053-36242020-06-017110.1136/openhrt-2019-001203Impact of preinterventional tricuspid regurgitation on outcome of MitraClip therapy in patients with severely reduced ejection fractionTakayuki Gyoten0Daniel Messroghli1Soeren Schenk2Kristin Rochor3Oliver Grimmig4Soeren Just5Dirk Fritzsche6Cardiac Surgery, Sana-Herzzentrum Cottbus, Cottbus, Brandenburg, GermanyCardiology, Deutsches Herzzentrum Berlin, Berlin, GermanyCardiac Surgery, Sana-Herzzentrum Cottbus, Cottbus, Brandenburg, GermanyCardiac Surgery, Sana-Herzzentrum Cottbus, Cottbus, Brandenburg, GermanyCardiac Surgery, Sana-Herzzentrum Cottbus, Cottbus, Brandenburg, GermanyCardiac Surgery, Sana-Herzzentrum Cottbus, Cottbus, Brandenburg, GermanyCardiac Surgery, Sana-Herzzentrum Cottbus, Cottbus, Brandenburg, GermanyAimTo evaluate the impact of preinterventional moderate-to-severe functional tricuspid regurgitation (FTR) on early outcome after percutaneous edge-to-edge mitral valve repair (pMVR) with MitraClip procedures for functional mitral regurgitation (FMR) in patients with heart failure with reduced ejection fraction (HFrEF).Methods and resultsFrom January 2013 to December 2017, 80 patients with HFrEF (ejection fraction 22%±5.3%) and FMR (grade 3.0±0.36) underwent successful pMVR. The 3-year actuarial survival was 58%. However, 73% (n=22) of non-survivors died of cardiac failure within 1 year. Patients were categorised into none-to-mild (n=36) and moderate-to-severe (n=44) postinterventional FTR groups according to pre-MitraClip tricuspid regurgitation grade. Cox regression analysis on 1-year survival demonstrated an impact of FTR severity (HR=1.8, 95% CI 1.01% to 3.09%, p=0.047), preoperative New York Heart Association class (HR=2.8, 95% CI 1.2% to 6.5%, p=0.015) and peripheral artery disease (HR=5.4, 95% CI 1.6 to 18, p=0.0054). Kaplan-Meier analysis showed that 1-year cardiac death was higher in the moderate-to-severe FTR group (p=0.048). In our study, 77% of pre-MitraClip moderate-to-severe FTR cannot be significantly reduced. Post-MitraClip moderate-to-severe FTR grade was related to lower survival (p<0.001).ConclusionIn patients with HFrEF treated with MitraClip for FMR, moderate-to-severe FTR was an independent predictor of cardiac death within 1 year. To improve survival, additional therapy to residual FTR should be considered in early phase after MitraClip therapy.https://openheart.bmj.com/content/7/1/e001203.full |
spellingShingle | Takayuki Gyoten Daniel Messroghli Soeren Schenk Kristin Rochor Oliver Grimmig Soeren Just Dirk Fritzsche Impact of preinterventional tricuspid regurgitation on outcome of MitraClip therapy in patients with severely reduced ejection fraction Open Heart |
title | Impact of preinterventional tricuspid regurgitation on outcome of MitraClip therapy in patients with severely reduced ejection fraction |
title_full | Impact of preinterventional tricuspid regurgitation on outcome of MitraClip therapy in patients with severely reduced ejection fraction |
title_fullStr | Impact of preinterventional tricuspid regurgitation on outcome of MitraClip therapy in patients with severely reduced ejection fraction |
title_full_unstemmed | Impact of preinterventional tricuspid regurgitation on outcome of MitraClip therapy in patients with severely reduced ejection fraction |
title_short | Impact of preinterventional tricuspid regurgitation on outcome of MitraClip therapy in patients with severely reduced ejection fraction |
title_sort | impact of preinterventional tricuspid regurgitation on outcome of mitraclip therapy in patients with severely reduced ejection fraction |
url | https://openheart.bmj.com/content/7/1/e001203.full |
work_keys_str_mv | AT takayukigyoten impactofpreinterventionaltricuspidregurgitationonoutcomeofmitracliptherapyinpatientswithseverelyreducedejectionfraction AT danielmessroghli impactofpreinterventionaltricuspidregurgitationonoutcomeofmitracliptherapyinpatientswithseverelyreducedejectionfraction AT soerenschenk impactofpreinterventionaltricuspidregurgitationonoutcomeofmitracliptherapyinpatientswithseverelyreducedejectionfraction AT kristinrochor impactofpreinterventionaltricuspidregurgitationonoutcomeofmitracliptherapyinpatientswithseverelyreducedejectionfraction AT olivergrimmig impactofpreinterventionaltricuspidregurgitationonoutcomeofmitracliptherapyinpatientswithseverelyreducedejectionfraction AT soerenjust impactofpreinterventionaltricuspidregurgitationonoutcomeofmitracliptherapyinpatientswithseverelyreducedejectionfraction AT dirkfritzsche impactofpreinterventionaltricuspidregurgitationonoutcomeofmitracliptherapyinpatientswithseverelyreducedejectionfraction |